Am J Transplant, Volume 19, Suppl 3 Archives - Page 30 of 214 - ATC Abstracts

2019 American Transplant Congress
Outcome of Treated Cellular Rejection (CMR) in Renal Transplant Patients
N. Raj, S. Jackson, S. Riad, R. Spong, V. Vakil, A. Matas, D. Keys
University of Minnesota, Minneapolis, MN
*Purpose: Prior studies have shown that after treatment of CMR, lack of return to baseline creatinine (Cr.) is associated with increased graft loss. We sought…
2019 American Transplant Congress
BMI Changes and Its Impact on Long Term Follow-Up in Kidney Transplant Recipients
P. A. Miarka, D. Cieniawski, E. Ignacak, A. Prokop, A. Hodun, K. Krzanowska, M. Kuzniewski
Dept. of Nephrology, Jagiellonian University Medical College, Krakow, Poland
*Purpose: BMI has an effect on patients with chronic kidney disease (CKD) and after kidney transplantation (ktx). Higher body weight and use of immunosuppressive treatment…
2019 American Transplant Congress
Novel Oral Anticoagulants in Kidney Transplantation: Results from a Pilote Study
J. Leon, J. Zuber, L. Amrouche, D. Anglicheau, G. Divard, C. Legendre, R. Sberro-Soussan
Adult Transplantation, Necker Hospital, Paris, France
*Purpose: Oral anticoagulation therapy is frequently prescribed to kidney transplant recipients, for prevention and treatment of thrombotic events. Over the past ten years, novel oral…
2019 American Transplant Congress
Dialysis Lowers Pulmonary Embolism Mortality Risk in Kidney Transplantation
B. Javaid, A. Gilbert, G. Vranic, J. Moore, B. Thomas, P. Abrams, S. Ghasemian, J. Verbesey, S. Yi, M. Cooper
MedStar Georgetown Transplant Institute, Georgetown University School of Medicine, Washington, DC
*Purpose: The primary purpose of this study was to assess the risk of mortality attributed to pulmonary embolism in kidney transplant recipients. We also wanted…
2019 American Transplant Congress
Anti-ebv Antibody (ebv-ab) And Ebv-specific Cytotoxic T Cell (ebv-tc) Positivity Are Essential To Control Viremia In Seronegative (sero[-]) Pediatric Kidney Transplant Recipients (ped Ktx Pts).
B. Shin, H. Pizzo, D. Puliyanda, A. Petrosyan, D. Lovato, S. C. Jordan, M. Toyoda
Cedars-Sinai Medical Center, Los Angeles, CA
*Purpose: EBV infection represents a significant morbidity factor in KTx Pts, especially EBV sero(-) Ped as infections tend to be more severe and recurrent, increasing…
2019 American Transplant Congress
Timeline for Resuming Physical Activities after Renal Transplantation: A Mid West Pediatric Nephrology Consortium Study
P. Baddi¹, H. Patel², H. Janjua³, D. Y. Kim⁴, A. Jain⁵
¹Beaumont Children's Hospital, Royal Oak, MI, ²Nationwide Children's Hospital, Columbus, OH, ³Cleveland Clinic Children's Hospital, Cleveland, OH, ⁴Children's Hospital of Michigan and Henry Ford Hospital, Detroit, MI, ⁵Children's Hospital of Michigan, Detroit, MI
*Purpose: To assess the practice patterns of the timeline for safely resuming various physical activities after pediatric kidney transplant.*Methods: An anonymous web-based survey was distributed…
2019 American Transplant Congress
Polyomavirus Genotypes In Renal Transplant Recipients In The United States
N. Khoury¹, C. Thongprayoon², N. Leeaphorn³, J. Bruminhent⁴, W. Cheungpasitporn⁵
¹Henry Ford Transplant Institute, Detroit, MI, ²Mayo Clinic, Rochester, MN, ³University of Missouri, Kansas, MO, ⁴Mahidol University, Bangkok, Thailand, ⁵University of Mississippi, Jackson, MS
*Purpose: BK Polyomavirus (BKV) subtypes and subgroups present uneven geographical distribution, suggesting a potential relationship with ethnicity. In the United States where there is a…
2019 American Transplant Congress
The Utility Of Intraoperative Vascular Anastomotic Inflow Measurements In Donation After Circulatory Death (DCD) Liver Transplantation
A. Nair, L. Coromina Hernandez, K. Sasaki, C. Kwon, T. Diago Uso, M. Fujiki, F. Aucejo, K. Hashimoto, B. Eghtesad, C. Miller, C. Quintini
Cleveland Clinic, Cleveland, OH
*Purpose: The use of flow probes to measure hepatic inflow at the conclusion of vascular anastomoses in Donation after Circulatory Death (DCD) liver transplantation is…
2019 American Transplant Congress
The Feasibility Of Donation After Cardiac Death In Liver Transplantation: A Registry Analysis
A. C. Gruessner, R. Misawa, A. Masi, Z. Moghadamyeghaneh, J. F. Renz, R. W. Gruessner
SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: Utilization of liver allografts from donation after cardiac death (DCD) has gradually increased in the United States. We aimed to analyze overall utilization of…
2019 American Transplant Congress
Intraoperative Blood Loss and Transfusion during Pediatric Liver Transplantation: A Single Center Experience
J. A. Villarreal¹, D. Yoeli², J. Yoeli³, R. Ackah⁴, R. Sigireddi¹, M. Kueht¹, N. Galvan¹, R. Cotton¹, A. Rana¹, C. O’Mahony¹, J. Goss¹
¹Surgery, Baylor College of Medicine, Houston, TX, ²Surgery, University of Colorado School of Medicine, Denver, CO, ³Pediatrics, University of Colorado School of Medicine, Denver, CO, ⁴Surgery, The Ohio State University College of Medicine, Columbus, OH
*Purpose: The aim of this study is to identify risk factors for massive intraoperative blood loss and transfusion in pediatric liver transplant recipients and describe…